Sareum Holdings plc (RYH0)
FSX
Closed
Oct 7, 2026
Day's Range
0.244052 wk Range
0.0700Overview - RYH0 - Sareum Holdings plc
Key Statistics
Valuation
Enterprise Value
46.16M
P/E (Trailing)
‪-12.33‬
Price / Book
‪28.20‬
EV / EBITDA
‪-13.65‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.70%‬
Return on Equity
‪-178.45%‬
Ownership
Shares Outstanding
138.06M
Float
132.72M
Held by Insiders
‪6.43%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-0.54‬
50-Day Avg
‪0.2693‬
200-Day Avg
‪0.2020‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RYH0 - Sareum Holdings plc
Peers - RYH0 - Sareum Holdings plc
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- RYH0FSXSareum Holdings plc41.35MMarket Cap+9.46%52-week change-12.33P/E (Trailing)‪0.00%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - RYH0 - Sareum Holdings plc
About
Sareum Holdings plc is a biotechnology company focused on the discovery and development of innovative cancer therapeutics. The primary purpose of Sareum Holdings is to utilize its expertise in medical research to develop small molecule therapeutics, aiming to target various forms of cancer by inhibiting specific…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
